rank ligand
Zoeken
Gevonden resultaten: 1
Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ... « rank-ligand
(Klikken: 152;website toegevoegd: Mar 24, 2014, rank-ligand)
Prolia® (denosumab), the first and only approved RANK Ligand inhibitor, has filed for approval worldwide for the treatment of postmenopausal osteoporosis.
